Other surgical procedures include transurethral needle ablation (TUNA) also known as radiofrequency ablation,
transurethral microwave therapy (TUMT), laser treatments, and stenting of the urethra.
Across the guidelines, minimally invasive therapies, specifically
transurethral microwave therapy and transurethral needle ablation of prostate, were considered as alternatives in patients with moderate or severe LUTS, with small to moderate gland size, and with the desire to avoid invasive therapy due to clinical risk for cardiopulmonary complication (Table 4).
For more than a decade, men with benign prostatic hyperplasia (BPH, or enlarged prostate) who don't benefit from medications or don't want surgery have had a minimally invasive option in
transurethral microwave therapy (TUMT).